Anti-CD38 single-domain antigen-binding fragments as theranostics in the management of multiple myeloma
Promoter: Yves Beguin (Yves.Beguin@uliege.be)
Co-promoters: Mireille Dumoulin (mdumoulin@uliege.be) & Jo Caers (jo.caers@chu.ulg.ac.be)
Related publication:
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma; Duray E, Lejeune M, Baron F, Beguin Y, Devoogdt N, Krasniqi A, Lauwers Y, Zhao YJ, D'Huyvetter M, Dumoulin M, Caers J. J Hematol Oncol. 2021 Nov 2;14(1):183. doi: 10.1186/s13045-021-01171-6.
Caers, J., Duray, E., Dumoulin, M., & D’Huyvetter, M. (15 May 2020). Anti-CD38 Single-domain antibodies on disease monitoring and treatment (Patent). https://hdl.handle.net/2268/255626.
